Program details
-
Diabetes and cancer
Unveiling the connection between diabetes and cancer
Chair(s): Chang Beom Lee, Jeong Hyun Park
Friday 16 October, 13:40~15:00
Room 4
-
This session explores the diabetes-cancer nexus, analyzing the metabolic landscape of cancer prognosis from an epidemiological perspective. It will examine how underlying mechanisms—specifically hyperinsulinemia and chronic inflammation—drive tumor progression. Furthermore, the role of antidiabetic agents will be investigated, exploring potential risks alongside protective anti-cancer benefits. Ultimately, this session highlights vital translational insights, establishing a clearer framework for future therapeutic strategies and optimized patient outcomes.
-
-
S07-L1
Sixten HarborgAarhus University, Denmark
-
The metabolic landscape of cancer prognosis: an epidemiologic perspective
-
S07-L2
Yeon Kyung ChoiKyungpook National University, Korea
-
Hyperinsulinemia, inflammation, and cancer: mechanisms
-
S07-L3
Chang Hee JungUniversity of Ulsan, Korea
-
Impact of anti-diabetic agents on cancer risk: focusing on GLP-1 RA and SGLT2i
-
Beyond vascular complications
Emerging non-vascular burden of diabetes
Chair(s): Won-Young Lee, Byung-Wan Lee
Friday 16 October, 16:00~17:20
Room 1
-
Diabetes complications extend beyond traditional microvascular and macrovascular outcomes. This session, Emerging Non-Vascular Burden of Diabetes, explores the expanding spectrum of diabetes-related complications through the CKM framework, the bidirectional relationship between MASLD and diabetes, and diabetes-associated cognitive decline with emphasis on neurodegeneration. Together, these topics broaden perspectives on diabetes complications and highlight integrated approaches to prevention, risk assessment, and patient-centered care.
-
-
S09-L1
Soo LimSeoul National University, Korea
-
Expanding spectrum of complication of diabetes based on CKM concept
-
S09-L2
Norbert StefanUniversity Tübingen, Germany
-
Interplay between MASLD and diabetes
-
S09-L3
Hee-Jin KimHanyang University, Korea
-
Diabetes and cognitive decline: focusing on neurodegeneration
-
Rejuvenation and longevity
Clinical and translational approaches to healthy longevity
Chair(s): Seok Won Park, Eun-Hee Cho
Saturday 17 October, 13:30~14:50
Room 3
-
This symposium explores healthy longevity through the interconnected roles of aging biology, metabolic dysfunction, kidney health, cellular senescence, and systemic circulating factors. By integrating epidemiologic, tissue-level, and mechanistic perspectives, the session highlights how fundamental aging processes contribute to diabetes-related complications and chronic disease burden. These insights may advance novel preventive and therapeutic strategies, fostering healthier aging and improving long-term outcomes for individuals with diabetes.
-
-
S14-L1
Shigeo HorieJuntendo University, Japan
-
Aging, kidney health, and diabetes: epidemiologic implications for healthy longevity
-
S14-L2
James L. KirklandCedars-Sinai Medical Center, USA
-
Towards validating the unitary hypothesis: are fundamental aging mechanisms in adipose depots concentrated within tissue crown-like structures?
-
S14-L3
Jae-Ryong KimYeungnam University, Korea
-
Targeting cellular senescence with homoharringtonine: from metabolic health to longevity
